GSK CEO Calls For Change In Business Model As World Power Moves To Emerging Economies
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Fifty years from now, the period between 2005 and 2020 may be seen as critical years of change when the world witnessed a fundamental shift in economic power from a model dominated for the last 250 years to an evolutionary one led by emerging markets rather than Western economies
You may also be interested in...
GSK Senior VP Rogerio Ribeiro On Trends In Emerging Markets: An Interview With PharmAsia News
GSK operates in 172 emerging markets, which represented about 22% of the company’s revenues in 2013, and EM Head Rogerio Ribeiro is optimistic about further growth despite challenges in some markets.
GSK Shoots For Next Growth Phase In India With Bigger Push Into Vaccines, Pharma And Consumer Health
For the first time, the global board of directors of the British pharma and consumer healthcare giant met in India, and a series of moves to power further growth could be on the way.
GSK Shoots For Next Growth Phase In India With Bigger Push Into Vaccines, Pharma And Consumer Health
For the first time, the global board of directors of the British pharma and consumer healthcare giant met in India, and a series of moves to power further growth could be on the way.